Denosumab, teriparatide and bisphosphonates for glucocorticoid-induced osteoporosis: a Bayesian network meta-analysis

Conclusion: Teriparatide denosumab and the bisphosphonates are all effective in improving BMD for GIO patients. Based on this network meta-analysis, teriparatide and denosumab have higher efficiency in improving lumbar spine and femur neck BMD, and reducing vertebrae fracture.Systematic Review Registration:10.17605/OSF.IO/2G8YA, identifier CRD42023456305.
Source: Frontiers in Pharmacology - Category: Drugs & Pharmacology Source Type: research